Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

A report in the Wall Street Journal, citing people familiar with the matter, suggested an announcement of a transaction could ...

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...

While simply using fresh herbs can really improve the overall flavor of roasted vegetables, a splash of acid can take that ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and ...

January 5, 2026 Citrus Burn is a citrus-derived dietary supplement formulated to support metabolism, daily energy levels, and ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

Before you turn to dietary supplements, the most effective winter "supplement" is plain old soap, said Vernarelli. "The best ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.